...
首页> 外文期刊>International Journal of Pharmaceutics >Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
【24h】

Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.

机译:在制备难溶性API的固体分散体中使用表面活性剂作为增塑剂:使用溶解度参数选择聚合物-表面活性剂组合并测试可加工性。

获取原文
获取原文并翻译 | 示例
           

摘要

Formation of solid dispersions as a means to enhance the dissolution rate of poorly soluble Active pharmaceutical ingredients (APIs) typically employs hydrophilic polymer systems and surfactants. While the utility of the surfactant systems in solubilization is well known, the secondary effects of the same on processing and subsequent physical stability of the solid dispersions needs to be studied further. Physical blends of the poorly soluble API and hydrophilic polymers such as PVP-K30, Plasdone-S630, HPMC-E5, HPMCAS, and Eudragit L100 with mass ratio 1:1 were prepared. The surfactants tested in this study included Tween-80, Docusate sodium, Myrj-52, Pluronic-F68 and SLS. Thermal analysis of the API-polymer-surfactant blends suggested that the surfactants caused solvation/plasticization, manifesting in reduction of (i) the melting (T(m)) of API (ii) T(g) of the polymers and (iii) the combined T(g) of the solid dispersion formed from quench cooling. Explanation of these effects of surfactants is attempted based on their physical state (at the temperature of interest), HLB values and similarity of their solubility parameter values with respect to drug-polymer systems. Furthermore, extruded matrices containing different API-polymer (PVP-K30, Plasdone-S630, and HPMC-E5) mixtures prepared with and without surfactants, were produced by feeding the powder blend through a hot-melt extruder. The melt viscosity of the polymer blends was assessed by torque rheometry using a Haake Rheomix. The physicochemical properties of the extruded API-polymer-surfactant were characterized by differential scanning calorimetry, X-ray diffraction, Raman spectroscopy, and polarized microscopy. The results demonstrated that the glass transition temperature of the carrier polymers decreased as direct result of the surfactants in the extrudate, due to an increase in the chain mobility of polymers. A decrease in the melt viscosity was seen due to a plasticization of the polymer. The drug release profiles of the extruded solid dispersions containing intra granular surfactants were found to fit the dispersions with extra granularly added surfactants.
机译:形成固体分散体作为提高难溶性活性药物成分(API)溶解速率的手段,通常采用亲水性聚合物体系和表面活性剂。尽管表面活性剂体系在增溶中的用途是众所周知的,但是其对固体分散体的加工和随后的物理稳定性的次要作用需要进一步研究。制备了质量比为1:1的难溶性API和亲水性聚合物(例如PVP-K30,Plasdone-S630,HPMC-E5,HPMCAS和Eudragit L100)的物理混合物。在这项研究中测试的表面活性剂包括Tween-80,Docusate钠,Myrj-52,Pluronic-F68和SLS。 API-聚合物-表面活性剂混合物的热分析表明,表面活性剂引起溶剂化/增塑,表现为(i)API(ii)熔融(T(m))(ii)聚合物T(g)和(iii)的降低。由骤冷形成的固体分散体的合并T(g)。尝试根据表面活性剂的物理状态(在目标温度下),HLB值以及其溶解度参数值相对于药物-聚合物体系的相似性来解释这些表面活性剂。此外,通过将粉末共混物送入热熔挤出机中,制得了含有和不含表面活性剂的不同API聚合物(PVP-K30,Plasdone-S630和HPMC-E5)混合物的挤出基质。使用Haake Rheomix通过扭矩流变法评估聚合物共混物的熔体粘度。通过差示扫描量热法,X射线衍射,拉曼光谱和偏光显微镜对挤出的API聚合物表面活性剂的理化性质进行了表征。结果表明,由于聚合物链迁移率的增加,由于挤出物中表面活性剂的直接作用,载体聚合物的玻璃化转变温度降低。由于聚合物的增塑,发现熔融粘度降低。发现含有内部颗粒状表面活性剂的挤出固体分散体的药物释放曲线使分散体具有额外的颗粒状添加的表面活性剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号